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922 This article is published in Cell Stem Cell, 15One of the most fascinating observations
in the last few years in the field of hemato-
poietic stem cell (HSC) biology is that
quiescence, the physiological state of
dormancy that maintains the self-renewal
of adult blood-forming HSCs, is governed
primarily by metabolism. Hence, self-re-
newing HSCs rely mainly on anaerobic
glycolysis for energy production, with a
dash of fatty acid metabolism to support
complex fate decisions like symmetric
versus asymmetric divisions. At the
same time, oxidative phosphorylation by
the mitochondria has to be actively pre-
vented to maintain cell quiescence. In
contrast, HSC differentiation and active
blood production requires the engage-
ment of the TCA cycle to generate high
levels of ATP, as well as increased pro-
duction of reactive oxygen species
(ROS) as a byproduct of mitochondrial ac-
tivity, to help jump-start lineage commit-
ment programs. While the hunt for the
ultimate combination of surface markers
that solely enrich for engrafting HSCs is
still on, I have come to redefine HSCs
based on their metabolic plasticity and
ability to transition from dormancy to ac-
tivity over a continuum of marker expres-
sion. Hence, in my view, the metabolic
state and quiescent status, rather than
the phenotypic identity, are the most
important criteria for defining engrafting
HSCs. This updated operational definition
opens new perspectives for understand-
ing HSC function in normal and disease
contexts and for expanding engrafting
HSCs in vitro for clinical applications.,6, 10Dynamic PSC Mitochondria.1016/j.stem.2014.11.013, December 4, 2014. AdvanCells consume nutrients for sustenance,
replication, and function. Pluripotent stem
cell (PSC) apportioning of resources for
energy and biomolecules regulates self-
renewal and differentiation potential. The
mitochondrion is central in this metabolic
networkof life. InnaivePSCs,mitochondria
are nonfusedandperinuclear andgenerate
ATP. Metabolism shifts in ‘primed’ PSCs
to emphasize glycolysis, with ATP hy-
drolysis maintaining the mitochondrial
membrane potential. Upon differentiation,
mitochondria fuse into a cytoplasmic
network and return to ATP production.
With somatic cell reprogramming to plurip-
otency these processes are reversed.
Many questions about mechanisms
and integration of these mitochondrial
changes remain unanswered, which
could impact cell therapies. For example,
what factors control position, network
status, turnover, and relationship to the
endoplasmic reticulum? When do these
changes occur, and how do they impact
energetics, Ca2+ regulation, Fe/S clus-
ters, and apoptotic sensitivity? How do
TCA cyclemetabolite levels or differences
in growth media affect epigenetic en-
zymes that regulate gene expression?
What sensors establish lineage-specific
mtDNA and mass levels? How is respira-
tory capacity increased with differentia-
tion and lowered with reprogramming?
When is mitophagy activated? How are
mitochondria integrated with HIFs, which
promote self-renewal or differentiation
depending upon stimuli? In sum,much re-
mains to be learned about howmitochon-
dria regulate PSC fate.ce apEndogenous Small Moleculespearance here with permission. ª2014 Elsevier Inc.In recent years, it’s become clear that
‘‘endogenous’’ small molecules derived
from cell metabolism (e.g., metabolites
of cellular nutrients and building blocks)
contribute to modulation of cell fate
(e.g., stem cell differentiation or cancer
cell growth) and state. They can function
as ligands of receptors, modulators of
enzyme activities (e.g., histone modifying
enzymes and metabolic enzymes), or
participants in protein modifications to
directly control cellular signaling and tran-
scriptional, epigenetic, and metabolic
mechanisms. Conversely, the generation
of different pools of these small molecules
at various levels is controlled by cell-type-
and state-specific expression of meta-
bolic enzymes, microenvironments (e.g.,
nutrient input and stress), and certain
cellular processes (e.g., autophagy). This
interplay constitutes the robustness of
cell fate and orchestrates cell fate transi-
tion. Consequently, manipulation of
cellular metabolism by exogenous small
molecules that change a cohort of metab-
olites provides a powerful approach to
controlling cell fate.
Continued efforts in metabolomics and
especially in deorphanization of receptors
will undoubtedly contribute to increased
understanding of the abovementioned
mechanisms. This would require compre-
hensive cataloging of all metabolites, true
metabolic profiling of different cell types/
states, integration with other molecular
‘‘-omics’’ and cellular functional data
sets, and new technology developments
in addressing these challenges.
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This article is published in Cell Stem Cell, 15,6, 10.1Many somatic stem cells persist in a
quiescent state until extrinsic signals
induce them to activate, proliferate, and
produce differentiated progeny. Typically,
while quiescent stem cells are tiny, with
scant cytoplasm and few mitochondria,
they enact quiescence-specific transcrip-
tional and epigenetic programs. Yet little
is known about the bioenergetic require-
ments of the quiescent state or the meta-
bolic pathways that generate ATP to
support those needs. Deciphering this
issue will require sensitive and specific
probes that distinguish among metabolic
pathways and can be used in vivo to
address these issues adequately.
By contrast, the activation of stem cells
out of quiescence poses an enormous en-
ergetic challenge. Support is needed for
massive cell growth prior to division and
for extensive macromolecular and organ-
elle biosynthesis. Energetic and biosyn-
thetic demands are inextricably coupled,
and activation may represent a state of
relative nutrient deprivation as demand
exceeds supply. A major challenge is to
model how metabolic pathways impor-
tant for generating high-energy phos-
phates are modified to accommodate
needs for biomass in the form of sub-
strates, not just cofactors, for biosynthetic
activity. In addition, advances in metabo-
lomics are required to reveal how cata-
bolic processes such as autophagy and
protein degradation are critical to main-
tain substrate and metabolite levels that
support the bioenergetic and biosynthetic
needs of stem cells activating out of
quiescence.016/j.Editing Cellular Energeticsstem.2014.11.013,, December 4, 2014. Advance apMitochondria play fundamental roles in
energy production and metabolism, and
mutations in mitochondrial DNA (mtDNA)
lead to devastating maternally inherited
disorders. Recent reports show that
mutant mtDNA can be spontaneously
reduced during iPSC reprogramming or
specifically eliminated from somatic cells
using gene editing tools. These advances
will help guide the development of new
cell therapies for mitochondrial diseases.
Though these advances are encouraging,
somatic cell approaches cannot always
prevent mitochondrial disease transmis-
sion to the next generation. Prenatal diag-
nosis, while useful, fails to completely
prevent transmission of mitochondrial
diseases due to the random segregation
of mtDNA. Thus, germline modifications
are needed to correct such disorders.
Mitochondrial replacement techniques,
which require the use of healthy donor
oocytes or embryos, are currently being
developed and are under evaluation by
government authorities. In parallel, the
development of new mtDNA gene editing
technologies may not be that far away.
mtDNA gene editing techniques, when
applied to the patient’s own oocytes,
may revolutionize the treatment and
transmission of mitochondrial diseases
to our descendants. Notwithstanding the
hopes that these advances bring, it is
our responsibility as scientists to inform
and seek guidance from our society on
discoveries made in the laboratory that
may alter not only the course of certain
human diseases but even the evolution
of our own species.pearanThe Ecology of DNAce in here with permission. ª2014 Elsevier Inc. 92In the news, epigenetics is portrayed as
something having to do with your health
being affected by what your mother ate
or how stressed she was. Psychologists
talk about an epigenetic succession of
developmental stages of the human psy-
che. Let’s call this the world of macro
epigenetics. In the lab we talk about epi-
genetics as replicative chemistry on
DNA, histones and noncoding RNA in
stem cells and the germline. Let’s call
this theworld ofmicro epigenetics. Iwould
like to know how much the worlds of
macro and micro epigenetics overlap,
and how much metabolites acting in
stemcellsmediate suchoverlap. I suspect
that somemetabolites like acetyl-CoA are
as much second messengers as cyclic
AMP. Some nutrients like vitamin C are
as much hormones as estrogen. All these
voices talk to chromatin. In a future ‘‘the-
ory of everything epigenetics’’ that con-
nects our DNA all the way up to our
ecosystems, I hope that we will factor in
the two broad implications of such con-
nections: (1) pollution and climate change
are problems of profound epigenetic
consequence, rather than solely the realm
of ecologists; and (2) the ecosystems
within us speak to us as much as those
without. When Walt Whitman wrote, ‘‘I
am large, I contain multitudes,’’ he could
have been referring to the way our micro-
biome modulates our environment, and
theway our transposable elementsmodu-
late our responses.Weare symbionts, and
long have been, and epigenetics holds our
improbable balance together well before
birth all the way to dusty death.3
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924 This article is published in Cell Stem Cell, 15At the vanguard of future healthcare,
regenerative biology aims to address the
unmet needs of an aging global popula-
tion vulnerable to chronic diseases. De-
coding the mechanisms of tissue renewal
versus degeneration, in the context of
senescence and disease burden, has pro-
vided the foundation for regenerative
paradigms. Translating the principles of
natural rejuvenation will, in turn, pave the
way for novel reparative strategies and
the establishment of a science-driven
regenerative medicine model of care.
The way stem cells use energy and inter-
mediate metabolites determines their
function and ultimate fate. Plasticity in
stem cell metabolism is increasingly
recognized to be critical in support of em-
bryonic development, adult tissue ho-
meostasis, and innate healing throughout
life. Metabolism-dependent regulation of
epigenetics plays a key role in directing
cellular fate beyond matching energetic
demands of stage-specific states, and
enables stem cells and their progeny to
communicate and respond to changes
occurring within local niches in health
and disease. The aging/disease pheno-
type has independently been associated
with a decline in energy metabolism and
stem cell function, yet how they interact
in pathology remains unexamined. By
exploring the interface of these fields,
we hope to aid in the development of
therapeutic techniques that offer individu-
alized beneficial outcomes through tar-
geting energy metabolism in stem cells
for sustained rejuvenation of aging and
diseased tissues.,6, 10Metabolism of Old Stem Cells.1016/j.stem.2014.11.013, December 4, 2014. AdvanAging is accompanied by a decline in
tissue regeneration and adult stem cell
function, which may underlie frailty and
system failure in old age. Intriguingly,
many genetic and environmental strate-
gies that delay organismal aging point to
metabolic pathways, such as the insulin-
FOXO, mTOR, and AMPK pathways.
Recent evidence indicates that these cen-
tral longevity pathways play a key role in
adult stem cell maintenance. It will be
exciting to explore how aging and
longevity pathways alter the metabolic
state of stem cells and whether an old
metabolism can be ‘‘rejuvenated’’ to a
younger one to improve stem cell func-
tion. It is striking to note that metabolites
are often used as cofactors for enzymes
that modulate chromatin states, which
are key for cell fate determination. Deci-
phering the connection between meta-
bolism and epigenetic states in stem
cells should provide key insights into
how long-lasting changes to stem cell
fate are implemented and how they
change throughout life. Finally, the advent
of new technologies is allowing the identi-
fication of novel metabolites in single cells
or in blood. These advances have the po-
tential to reveal new metabolic pathways
within stem cells and to decipher new
modes of communication between stem
cells and other cell types within a tissue
or at a distance via the blood circulation.
Looking forward, specific metabolites
could be developed as small molecules
to preserve stem cell function and prevent
general demise during aging.ce apMetabolism Dictates Cell Fatepearance here with permission. ª2014 Elsevier Inc.The resurgence of interest in metabolism
in the cancer field has metastasized to
the stem cell field. Currently, there are
two key aspects that I find exciting in
this area. First, we are working to delin-
eatemetabolic programs in stem, progen-
itor, and differentiated cells. We ask,
‘‘What are the metabolic pathways and
necessary fuels that maintain and distin-
guish each of these cell populations?’’
An interesting consideration is whether
rapidly proliferating stem cells utilize
different metabolic programs from rapidly
proliferating cancer cells. Resolving these
questions will rely on advances in metab-
olomics combined with genetic manipula-
tion of metabolic pathways. Identification
of such differences could revolutionize
cancer therapy by allowing more specific
targeting of cancer and avoiding
bystander damage to healthy stem and
progenitor cells.
A second provocative question is whether
metabolism can dictate stem cell renewal
and/or differentiation. It is well known that
signaling pathways converge on specific
transcriptional networks to promote
stem cell self-renewal and differentiation.
Conventionally, it is thought that meta-
bolism is altered as a consequence of
the chosen cell fate—that is, metabolic
demand drives the cell’s metabolic pro-
gram. However, emerging data suggest
that metabolism itself can alter transcrip-
tional networks to dictate cell fate, paving
the way for the possibility that we might
someday be able to regulate stem cells
through modulation of metabolism.
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This article is published in Cell Stem Cell, 15,6, 10.Over the past decade, our understanding
of the extrinsic signals generated by the
surrounding bone marrow microenviron-
ment that controls whether hematopoietic
stem cells (HSCs) self-renew, differen-
tiate, or remain quiescent has increased
significantly. At the same time, in the he-
matopoietic system, little is known about
the metabolic status and dependencies
of HSCs and progenitors. In my view,
how HSC metabolism is modulated by
inflammation and stress and the conse-
quences of these alterations warrant
further investigation. It is clear that the
increased energetic demands required
for the deregulated proliferation and sur-
vival of cancer cells often results in an
alteredmetabolic profile within these cells
via both cell-autonomous signals and
cues from the microenvironment. The
consequence of a tumor cell’s altered
metabolic profile may, in turn, also have
an impact on its neighboring niche cells
through the release of metabolic byprod-
ucts. Such metabolites could affect niche
cell function by acting as ligands for tran-
scription factors and/or substrates for
metabolic pathways or by modifying
innate immune cell fate. Therefore, inves-
tigations into this metabolic cross-talk
between leukemia cells and their micro-
environment via, possibly, the use of
in vivo imaging techniques should provide
an exciting further insight into our current
understanding of leukemia initiation and
development and may provide therapeu-
tic benefit in the future.1016/j.Aging Stem Cell Metabolismstem.2014.11.013,, December 4, 2014. Advance apStem cell dysfunction is a hallmark of ag-
ing. The widespread decline in regenera-
tive capacity associated with aging is
increasingly recognized as a critical driver
of tissue degeneration and associated
age-related diseases. Metabolic deregu-
lation, both systemically and locally, is
tightly linked to these phenotypes. How
stem cell metabolism is adversely
affected in aging tissues, whether such
changes are a consequence of systemic
metabolic changes or stem-cell-intrinsic
molecular changes, and whether inter-
ventions to ‘‘rejuvenate’’ stem cell meta-
bolism are viable strategies to improve
regeneration in aging tissues are all press-
ing questions that the field is starting to
explore. I believe that a combination of
advanced ‘‘-omics’’ approaches with ge-
netic studies that aim for in vivo charac-
terization and perturbation of regenerative
function inmodel organisms is going to be
the central strategy to resolve some of
these questions in the future. Clearly,
such strategies have already generated
exciting new insight into the interaction
of stem cells with their local and systemic
environment, factors influencing stem cell
metabolism in aging tissues, and possible
rejuvenating interventions. It can be antic-
ipated that we will continue to make sig-
nificant advances in this area in the next
few years, and these will contribute to
our goal of identifying targeted interven-
tions that allay and delay age-related pa-
thologies.pearance in here with permission. ª2014 Elsevier Inc. 925
